Related Experiment Video
Updated: Jun 12, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Calmodulin controls liver proliferation via interactions with C/EBPbeta-LAP and C/EBPbeta-LIP
Daniel Orellana1, Xiaoying Liu, Gou-Li Wang
1Huffington Center on Aging and Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas 77030, USA.
Calmodulin (CaM) inhibits liver proliferation by interacting with C/EBPbeta-LIP, a protein driving liver growth. This calcium-CaM signaling pathway regulates liver cell activity, supporting quiescence.
Area of Science:
- Hepatology
- Molecular Biology
- Cell Signaling
Background:
- The truncated C/EBPbeta-LIP isoform promotes liver proliferation and is elevated in tumors and during the acute phase response (APR).
- Mechanisms regulating C/EBPbeta-LIP activity in the liver, particularly during APR, are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms by which liver proliferation is regulated by C/EBPbeta-LIP.
- To investigate the role of calmodulin (CaM) and calcium signaling in controlling C/EBPbeta-LIP activity.
Main Methods:
- Investigated interactions between C/EBPbeta-LIP and calmodulin (CaM) in liver cells.
- Utilized mutant CaM and mouse models (LPS-treated) to assess the impact on liver proliferation.
- Examined the effect of C/EBPbeta-LIP on E2F-Rb complexes and cell cycle gene regulation.
Main Results:
- Calmodulin directly inhibits C/EBPbeta-LIP-driven liver proliferation during APR via Ca(2+)-dependent interactions.
- Reduced nuclear Ca(2+) during APR impairs CaM's inhibitory function, while increased Ca(2+) in proliferating livers enhances it.
- CaM down-regulation or C/EBPbeta-LIP overexpression in LPS-treated mice induces liver proliferation.
- C/EBPbeta-LIP disrupts E2F-Rb complexes to promote cell cycle gene expression, an effect inhibited by CaM.
Conclusions:
- Calcium-CaM signaling represents a novel regulatory pathway for liver proliferation by modulating C/EBPbeta-LIP activity.
- CaM's regulation of both C/EBPbeta-LIP and C/EBPbeta-LAP isoforms suggests a broad role in liver biology.
- This pathway offers potential therapeutic targets for liver diseases characterized by aberrant proliferation.
More Related Videos
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Non-Canonical Wnt Signaling Pathways
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cell Specific Gene Expression
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Master Transcription Regulators
